All In Biotech

Drug Trial Radar · NCT00385502

A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail

A Phase II Trial of the Safety, Local Tolerability, and Efficacy of EcoNail™ (Econazole 5%/SEPA® 18% Nail Lacquer) in Onychomycosis of the Great Toenail

Last checked: Nov 19, 2026Latest source record: Sep 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Sep 2006

Primary completion

Jun 2008

Study completion Jun 2008

Sponsor

Lead sponsor
Abeona Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Oct 9, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Approximately 40 qualified subjects with mild-to-moderate great toenail fungus infection will be treated for 48 weeks with lacquer application to at least one affected great toenail. All subjects will receive treatment with EcoNail™ lacquer.

Conditions

  • Onychomycosis

Interventions

  • EcoNail™ (econazole 5%/SEPA® 18% nail lacquer)Drug

    nail lacquer applied daily for 48 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determine effectiveness of EcoNail™ lacquer, as determined by effects on nail mycology and appearance, when applied daily for 48 weeks to diseased great toenails in subjects with onychomycosis.Time frame: Week 48

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Tucson, Arizona

  • Site not named

    New York, New York

  • Site not named

    Portland, Oregon

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.